Natural History of Sickle Cell Disease

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Study ID
NCT00081523
Status
Recruiting

Conditions

  • Pain Crisis

Eligibility Criteria

Sex
ALL
Age
2 Years - 90 Years
Healthy Volunteers
Not accepted

Study Details

This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center.

Key Dates

Start date
Apr 29, 2004
Status verified
Jun 2026

Study Design

Enrollment
3,500 participants (estimated)

Arms

  • Arm: Patients
    Individuals with known or suspected sickle cell disease

Primary Outcome Measure

To gather, through clinical experience, information regarding the natural history, co-morbid conditions and outcomes, and complications relating to sickle cell disease and other hemolytic disorders in minority/ethnic patients [ Time Frame: ongoing ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Childrens National Health CenterWashington D.C.District of Columbia20010
Deepika Darbari, M.D.
202-476-6393
National Institutes of Health Clinical CenterBethesdaMaryland20892
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222
Suburban HospitalBethesdaMaryland20814-

Find similar trials in Washington D.C., DC